Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11190079.1Aexternal-prioritypatent/EP2426141B1/en
Application filed by Glaxosmithkline Biologicals S.A.filedCriticalGlaxosmithkline Biologicals S.A.
Publication of CY1116106T1publicationCriticalpatent/CY1116106T1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Η παρούσα εφεύρεση παρέχει πολυπεπτίδια, πολυνουκλεοτίδια που περιλαμβάνουν αλληλουχία νουκλεϊνικού οξέος που κωδικοποιεί τα εν λόγω πολυπεπτίδια και σχετικές φαρμακευτικές συνθέσεις.The present invention provides polypeptides, polynucleotides comprising a nucleic acid sequence encoding said polypeptides and related pharmaceutical compositions.
CY20141101023T2005-04-292014-12-09
METHOD OF PREVENTION OR INFECTION TREATMENT M. TUBERCULOSIS
CY1116106T1
(en)
Method for the production of a marker contrast agent or marker therapeutic agent, marker contrast agents and use of marker contrast agents or marker therapeutic agents